|Day Low/High||86.90 / 87.01|
|52 Wk Low/High||19.62 / 87.01|
Stock closed higher as investors bet the Federal Reserve will delay its looming rate hike as Greece flirts with default.
Stocks staged a comeback as investors bet the Federal Reserve will delay its looming rate hike as Greece moves closer to default.
Stocks give up some of their gains on Tuesday, as a default on Greece's debt payment due to the International Monetary Fund looks unavoidable.
U.S. stock futures are rising in the face of a potential Greek debt default. Today investors will be wrestling with uncertainty over Greece's -- and Europe's -- future.
Juno shares are rising after the company signed a 10 year $1 billion drug development deal with Celgene (CELG).
U.S. stock futures trade higher Tuesday as investors cling to hope that a last-minute deal will be made between Greece and its creditors.
I wonder why skepticism disappears so quickly these days.
Under terms of the 10-year collaboration, Celgene is buying 9.1 million shares of Juno at $93 per share -- a 102% premium to Juno's closing price of $46.30.
Celgene Corporation (Nasdaq:CELG) and Juno Therapeutics, Inc.
Cramer says he wouldn't mind owning Caterpillar, is waiting on Alcoa and is sticking with Cypress Semiconductor.
The Federal Reserve statement, Greece, selling the dollar and investor confidence all had a hand, Cramer says.
Juno Therapeutics (JUNO) stock is gaining this morning after the company had coverage started with a 'buy' at Maxim.
Two biotechs and two China-based Internet companies highlight our stocks to watch today, as they carry strong technical momentum.
Juno Therapeutics (JUNO) is the 'Chart of the Day.'
Juno Therapeutics' stock shows a very strong uptrend and Relative Strength.
Biotech columnist Adam Feuerstein answers readers' questions about health care.
Cramer likes Blackstone's yield but says Karyopharm Therapeutics is speculative.
Buy what you know and pay attention, Cramer says.
Delta Air Lines (DAL) lagged the S&P 500 Tuesday after reporting a steep decline in passenger unit revenue in May.
The market pulled back after a rally in crude oil was overshadowed by uncertainty over Greece and surging bond yields triggered a selloff among utilities.
Stocks are narrowly mixed during the final hour of trading Tuesday as earlier upward momentum fades.
Juno Therapeutics (JUNO) shares jumped following reports that AstraZeneca might be interested in a company like Juno.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.